New Oral Agents for Multiple Sclerosis, Including Novartis ...
PR-Inside.com (Pressemitteilung) - Wien,Austria
... Current Therapies? finds that Novartis/Mitsubishi Pharma's new agent, currently known as fingolimod (also called FTY-720) will outperform other emerging ...
See all stories on this topic